86 related articles for article (PubMed ID: 2173435)
1. [Prevention of deep vein thrombosis by enoxaparin after total hip prosthesis].
Vochelle N; Planes A
Agressologie; 1990 Mar; 31(3):145-8. PubMed ID: 2173435
[TBL] [Abstract][Full Text] [Related]
2. Comparison of antithrombotic efficacy and haemorrhagic side-effects of Clivarin versus enoxaparin in patients undergoing total hip replacement surgery.
Planes A
Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S33-5; discussion S37-8. PubMed ID: 8180327
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty.
Colwell CW; Spiro TE
Clin Orthop Relat Res; 1995 Oct; (319):215-22. PubMed ID: 7554633
[TBL] [Abstract][Full Text] [Related]
4. Enoxaparin prophylaxis in elective hip surgery.
Turpie AG
Acta Chir Scand Suppl; 1990; 556():103-7. PubMed ID: 1963014
[TBL] [Abstract][Full Text] [Related]
5. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.
Adolf J; Fritsche HM; Haas S; Hennig FF; Horbach T; Kastl S; Koppenhagen K; Michaelis HC; Rhamanzadeh R; Summa W; Wagner W; Weber U; Wolf H
Int Angiol; 1999 Jun; 18(2):122-6. PubMed ID: 10424367
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.
O'Brien BJ; Anderson DR; Goeree R
CMAJ; 1994 Apr; 150(7):1083-90. PubMed ID: 8137188
[TBL] [Abstract][Full Text] [Related]
8. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
[TBL] [Abstract][Full Text] [Related]
9. The post-discharge prophylactic management of the orthopedic patient with low-molecular-weight heparin: enoxaparin.
Nilsson PE; Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlund U; Nicolas S; Nylander G
Orthopedics; 1997 Feb; 20 Suppl():22-5. PubMed ID: 9048404
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty. A prospective, randomized, controlled, clinical trial.
Huo MH; Salvati EA; Sharrock NE; Brien WW; Sculco TP; Pellicci PM; Mineo R; Go G
Clin Orthop Relat Res; 1992 Jan; (274):35-46. PubMed ID: 1729021
[TBL] [Abstract][Full Text] [Related]
11. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
12. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.
Sandset PM; Dahl T; Stiris M; Rostad B; Scheel B; Abildgaard U
Semin Thromb Hemost; 1990 Oct; 16 Suppl():25-33. PubMed ID: 1962901
[TBL] [Abstract][Full Text] [Related]
13. The thromboprophylactic effect of a low-molecular-weight heparin (Fragmin) in hip fracture surgery. A placebo-controlled study.
Jørgensen PS; Knudsen JB; Broeng L; Josephsen L; Bjerregaard P; Hagen K; Jørgensen PK; Tørholm C
Clin Orthop Relat Res; 1992 May; (278):95-100. PubMed ID: 1314147
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation and thrombosis in patients with ovarian malignancy.
von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery. EMRO1 (Grupo Fstudio Multicintrico RO-11).
Moreno Gonzalez E; Fontcuberta J; de la Llama F
Hepatogastroenterology; 1996; 43(9):744-7. PubMed ID: 8799424
[TBL] [Abstract][Full Text] [Related]
16. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression.
Labas P; Ohrádka B; Vladimír J; Cambal M
Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727
[TBL] [Abstract][Full Text] [Related]
17. Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement.
Eriksson BI; Borris LC; Dahl OE; Haas S; Huisman MV; Kakkar AK; Misselwitz F; Muehlhofer E; Kälebo P
Thromb Res; 2007; 120(5):685-93. PubMed ID: 17292948
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the efficacy and tolerance of Kabi 2165 and standard heparin in the prevention of deep venous thrombosis in total hip prosthesis].
Barre J; Pfister G; Potron G; Droulle C; Baudrillard JC; Barbier P; Kher A
J Mal Vasc; 1987; 12 Suppl B():90-5. PubMed ID: 2834500
[TBL] [Abstract][Full Text] [Related]
19. [Clinical monitoring and prevention of deep vein thrombosis in an orthopedic department: use of enoxaparin for a year].
Fluh D
Agressologie; 1990 Mar; 31(3):151-3. PubMed ID: 2173436
[TBL] [Abstract][Full Text] [Related]
20. An international multicentre study: Clivarin in the prevention of venous thromboembolism in patients undergoing general surgery. Report of the International Clivarin Assessment Group.
Boneu B
Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S21-2. PubMed ID: 8180325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
